TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1473915

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 61

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 61
Study: 6749189

Group type: EXPERIMENTAL
Intervention: Anticholinergic agent (atropine methonitrate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adrenergic agent (salbutamol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of both agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticholinergic agent first
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adrenergic agent first
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tests sensitive to small‐airway and large‐airway function and lung volumes
Number of subjects: 0
Study: 30527596

Group type: EXPERIMENTAL
Intervention: Intensive multidomain intervention including dietary counseling
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Regular health advice
Number of subjects: 1260
Study: 28990190

Group type: EXPERIMENTAL
Intervention: Social Cognition and Interaction Training (SCIT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 36
Study: 26821876

Group type: EXPERIMENTAL
Intervention: Bilateral transversus abdominis plane block using 21 ml of 0.25% bupivacaine and 4.0 mg dexamethasone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Parenteral opioids alone (sham block with 21 ml 0.9% saline)
Number of subjects: 32
Study: 24021723

Group type: EXPERIMENTAL
Intervention: Facilitated physical activity
Number of subjects: 19
Study: 22517769

Group type: EXPERIMENTAL
Intervention: ROSE-010 100 μg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ROSE-010 300 μg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ROSE-010 30 μg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ROSE-010 (all doses)
Number of subjects: 46
Study: 19551441

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic splenectomy (HALS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Open splenectomy (OS)
Number of subjects: 27
Study: 17387189

Group type: EXPERIMENTAL
Intervention: Propofol (100 microg x kg(‐1) x min(‐1))
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Isoflurane (one minimum alveolar concentration)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sevoflurane (one minimum alveolar concentration)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 52
Study: 16085730

Group type: EXPERIMENTAL
Intervention: Pressure ventilation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Volume ventilation
Number of subjects: 13
Study: 12236441

Group type: EXPERIMENTAL
Intervention: 7.6% carbohydrate‐electrolyte solution (CES)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 13
Study: 11016338

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum (1200 mL of air injected under the right hemidiaphragm)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-pneumoperitoneum (no air injected)
Number of subjects: 16
Study: 8831533

Group type: EXPERIMENTAL
Intervention: Colonic J-pouch anastomosis
Number of subjects: 23

Group type: COMPARATOR
Intervention: Straight coloanal anastomosis
Number of subjects: 23
Study: 1462894

Group type: EXPERIMENTAL
Intervention: Recombinant tissue‐type plasminogen activator (rTPA), 1 mg/kg body weight (maximum 100 mg) during 4 hours, in addition to aspirin, heparin, and beta‐blockade
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Recombinant tissue‐type plasminogen activator (rTPA)
Number of subjects: 205
Study: 6376484

Group type: EXPERIMENTAL
Intervention: Isocarboxazid (active medication)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 60
Study: 30670279

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (10 days of oral vitamin A)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (10 days of placebo)
Number of subjects: 74
Study: 29751754

Group type: EXPERIMENTAL
Intervention: SASA! intervention
Number of subjects: 928

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 928
Study: 27121115

Group type: EXPERIMENTAL
Intervention: High-selenium lentils (65 g per day for 6 months)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Low-selenium lentils (65 g per day for 6 months)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: High-selenium lentils
Number of subjects: 400

Group type: COMPARATOR
Intervention: Low-selenium lentils
Number of subjects: 400
Study: 24520782

Group type: EXPERIMENTAL
Intervention: Bawei Xilei Powder (BXP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Hydrocortisone edema solution
Number of subjects: 103
Study: 22640513

Group type: COMPARATOR
Intervention: Not applicable (no intervention reported)
Number of subjects: 1119
Study: 20215698

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 27
Study: 17586582

Group type: EXPERIMENTAL
Intervention: Aerobic training (n = 6)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) (n = 7)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention (Control) (n = 7)
Number of subjects: 20
Study: 16398599

Group type: EXPERIMENTAL
Intervention: Isolated soy protein
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isolated milk protein
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Soy + probiotic capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Milk + probiotic capsules
Number of subjects: 40
Study: 12087922

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg tablet (test formulation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Atenolol 100 mg tablet (reference formulation)
Number of subjects: 24
Study: 10617243

Group type: EXPERIMENTAL
Intervention: 5 mg simvastatin/d for 6 weeks
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 10 mg simvastatin/d for 6 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 8538903

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg/die (Group A, n = 10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg/die (Group B, n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg/die + Nitrendipine 20 mg/die (Group C, n = 10)
Number of subjects: 40
Study: 31899122

Group type: EXPERIMENTAL
Intervention: Liposomal irinotecan (nal-IRI) plus 5-FU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 0
Study: 29796238

Group type: EXPERIMENTAL
Intervention: Robot-based gestural training (four 30-min sessions with a social robot, NAO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Robot-based gestural training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 30
Study: 27179796

Group type: EXPERIMENTAL
Intervention: Body position at -6°
Number of subjects: 10

Group type: COMPARATOR
Intervention: Body position at 45°
Number of subjects: 10

Group type: COMPARATOR
Intervention: Body position at 75°
Number of subjects: 10
Study: 24291193

Group type: EXPERIMENTAL
Intervention: HPV-16/18 vaccine
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Participants with malaria
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group (without malaria or helminth infections)
Number of subjects: 298
Study: 23114828

Group type: EXPERIMENTAL
Intervention: FP with the conventional rigid bar splinting the implants
Number of subjects: 15

Group type: COMPARATOR
Intervention: Semi-rigid cantilever extension system with titanium bars placed in the 2 distal abutment cylinders
Number of subjects: 15
Study: 21087530

Group type: EXPERIMENTAL
Intervention: Sangustop®
Number of subjects: 126

Group type: COMPARATOR
Intervention: Tachosil® (carrier-bound fibrin sealant)
Number of subjects: 126
Study: 17146370

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) regimens including > or =3 agents
Number of subjects: 1498
Study: 15070635

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Combined ginkgo and acetazolamide
Number of subjects: 614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614

Group type: COMPARATOR
Intervention: Ginkgo biloba
Number of subjects: 614
Study: 12164804

Group type: EXPERIMENTAL
Intervention: Plasma exchange/fresh frozen plasma (PEX/FFP)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Plasma transfusion
Number of subjects: 2
Study: 9586422

Group type: EXPERIMENTAL
Intervention: Hexarelin (Hex) 2 micrograms/kg/bw i.v.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bromocriptine (Br) 2.5 mg po at time -60
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Br plus Hex
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Br
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hex
Number of subjects: 17
Study: 8575494

Group type: EXPERIMENTAL
Intervention: Etretinate 25 mg orally each day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 2773665

Group type: EXPERIMENTAL
Intervention: Nitroprusside infusion
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline infusion after ibuprofen
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nitroprusside infusion after ibuprofen
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 11
Study: 1108832

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31549356

Group type: EXPERIMENTAL
Intervention: Obese moderate persistent asthmatics (Group I)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Non-obese moderate persistent asthmatics (Group II)
Number of subjects: 320
Study: 31276178

Group type: EXPERIMENTAL
Intervention: Mail and monetary (guaranteed $10 on screening completion)
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Mail and lottery (1 in 10 chance of receiving $50 on screening completion)
Number of subjects: 838

Group type: COMPARATOR
Intervention: Mail only
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Mail and monetary
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Mail and lottery
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Mail and monetary or mail and lottery for Medicaid patients
Number of subjects: 838

Group type: COMPARATOR
Intervention: Mail only for non-Medicaid insured
Number of subjects: 838
Study: 28152236

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine treatment
Number of subjects: 302
Study: 25882337

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 60

Group type: COMPARATOR
Intervention: First-generation sirolimus-eluting stent (SES)
Number of subjects: 60
Study: 23154516

Group type: EXPERIMENTAL
Intervention: PRO‐SELF Pain Control Program (n = 58)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (n = 54)
Number of subjects: 112
Study: 21730080

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetes Support and Education Intervention
Number of subjects: 0
Study: 19690306

Group type: EXPERIMENTAL
Intervention: Nursing-led psychoeducational intervention (Project ENABLE) consisting of 4 weekly educational sessions and monthly follow-up sessions until death or study completion (n = 161)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Nursing-led psychoeducational intervention (Project ENABLE)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Usual care (n = 161)
Number of subjects: 322
Study: 17057557

Group type: EXPERIMENTAL
Intervention: Comorbidity Group (n=539)
Number of subjects: 7077

Group type: COMPARATOR
Intervention: Back Pain Group (n=6538)
Number of subjects: 7077
Study: 12937333

Group type: EXPERIMENTAL
Intervention: Patient behavior management only
Number of subjects: 167

Group type: COMPARATOR
Intervention: Patient behavior management plus caregiver stress-coping management
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 167
Study: 10716469

Group type: EXPERIMENTAL
Intervention: ST-segment resolution patterns
Number of subjects: 258

Group type: COMPARATOR
Intervention: TIMI flow grade
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: TIMI flow grade 0 & 1 with ST-segment resolution of > or =50%
Number of subjects: 258
Study: 9119635

Group type: EXPERIMENTAL
Intervention: BCG treatment (150 mg Pasteur BCG per instillation, 6-week induction course, single maintenance doses for 2 years)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Epirubicin treatment (50 mg per instillation, early instillation on postoperative day 2, followed by 4 weekly treatments and 10 monthly treatments for 2 years)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: BCG treatment in patients with stage T1 and grade 3 tumours
Number of subjects: 94
Study: 1394824

Group type: EXPERIMENTAL
Intervention: Intravenous methotrexate, vinblastine, Adriamycin, and cisplatin (M‐VAC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Factors analyzed included performance status (PS), M category, and dose of drugs
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: M category
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Presence of distant metastases
Number of subjects: 54
Study: 3157716

Group type: EXPERIMENTAL
Intervention: Queen's Tactile Vocoder
Number of subjects: 2
Study: 31005392

Group type: EXPERIMENTAL
Intervention: RP + AVF
Number of subjects: 97

Group type: COMPARATOR
Intervention: RP
Number of subjects: 97
Study: 29341404

Group type: EXPERIMENTAL
Intervention: canagliflozin 100 mg
Number of subjects: 1278

Group type: EXPERIMENTAL
Intervention: canagliflozin 200 mg
Number of subjects: 1278
Study: 26979068

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication treatment
Number of subjects: 93
Study: 24915612

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2a 180 μg/week
Number of subjects: 200

Group type: COMPARATOR
Intervention: ETV 0.5mg/day
Number of subjects: 200
Study: 22906892

Group type: EXPERIMENTAL
Intervention: Duodenum-preserving pancreatic head resection (DPPHR)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Pylorus-preserving pancreaticoduodenectomy (PPPD)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: DPPHR
Number of subjects: 85

Group type: COMPARATOR
Intervention: PPPD
Number of subjects: 85
Study: 20153063

Group type: EXPERIMENTAL
Intervention: Sun exposure practices and attitudes towards sunlight; 60% preferred to be outdoors; 92% believed sunlight was healthy; 90% preferred to be outdoors in their youth.
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Promotion of greater autonomy and improved physical access; More outdoor leisure activities.
Number of subjects: 57
Study: 18433464

Group type: EXPERIMENTAL
Intervention: Magnetic resonance direct thrombus imaging (MR DTI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Compression ultrasound
Number of subjects: 43
Study: 16296429

Group type: EXPERIMENTAL
Intervention: Twin‐motor sonic toothbrush (TST)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional sonic toothbrush (CST)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional electric toothbrush (CET)
Number of subjects: 36
Study: 12063586

Group type: EXPERIMENTAL
Intervention: Co-maintenance with propofol and midazolam (COM-group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: TIVA with propofol and fentanyl (Control-group)
Number of subjects: 40
Study: 9706062

Group type: EXPERIMENTAL
Intervention: Ranitidine 10 min after 0.04 micrograms/kg IV cholecystokinin (CCK)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Ranitidine 30 min after inflation of an occlusive duodenal balloon
Number of subjects: 4

Group type: COMPARATOR
Intervention: Ranitidine alone (control)
Number of subjects: 4
Study: 7618674

Group type: EXPERIMENTAL
Intervention: Propofol-nitrous oxide in oxygen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiopentone-isoflurane-nitrous oxide-oxygen (control)
Number of subjects: 60
Study: 2243896

Group type: EXPERIMENTAL
Intervention: Methysergide (4 mg p.o.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metergoline (4 mg p.o.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: MCPP (0.5 mg/kg p.o.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 445772

Group type: COMPARATOR
Intervention: Persistent medical therapy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Late surgery
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Late surgery patients
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Predictors of late surgery
Number of subjects: 106
Study: 31562005

Group type: EXPERIMENTAL
Intervention: Hepatitis B birth dose (HepB- BD)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Reasons for non-receipt of valid HepB-BD
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Maternal recommendations to improve valid HepB-BD uptake
Number of subjects: 344
Study: 30294974

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise (IDE)
Number of subjects: 11
Study: 28188383

Group type: EXPERIMENTAL
Intervention: Steady tapping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow tapping
Number of subjects: 0

Group type: COMPARATOR
Intervention: No tapping
Number of subjects: 0
Study: 26260718

Group type: EXPERIMENTAL
Intervention: Exposure to rudeness (mildly rude statements unrelated to performance)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (neutral comments)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rudeness
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Model specifying information-sharing and help-seeking as mediators
Number of subjects: 24
Study: 23921271

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 µg/kg/min after a loading dose of 12 µg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21140114

Group type: EXPERIMENTAL
Intervention: Palonosetron plus dexamethasone (PD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ondansetron plus dexamethasone (OD)
Number of subjects: 30
Study: 18378859

Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Home pulse pressure
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Nocturnal rise
Number of subjects: 392

Group type: COMPARATOR
Intervention: Ambulatory monitoring data
Number of subjects: 392
Study: 16601520

Group type: EXPERIMENTAL
Intervention: Aggressive screening with myocardial perfusion imaging
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Discussion of laboratory test results with providers
Number of subjects: 47

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 47
Study: 14752538

Group type: EXPERIMENTAL
Intervention: Buteyko Breathing Technique (BBT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 10877010

Group type: EXPERIMENTAL
Intervention: Caffeine (single oral dose)
Number of subjects: 17
Study: 9191757

Group type: EXPERIMENTAL
Intervention: ADAS-Cog
Number of subjects: 1648

Group type: EXPERIMENTAL
Intervention: Multiple regression model
Number of subjects: 1648
Study: 8193735

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg o.d.
Number of subjects: 18000

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure targets < or = 90 mmHg, < or = 85 mmHg, < or = 80 mmHg
Number of subjects: 18000

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg o.d. as basic antihypertensive treatment
Number of subjects: 18000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18000
Study: 3989697

Group type: EXPERIMENTAL
Intervention: 4 mg tablet formulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: syrup formulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4 mg tablet formulation with different inactive excipients
Number of subjects: 12
Study: 31505232

Group type: EXPERIMENTAL
Intervention: Interventional training based on self-directed learning to develop shared mental models
Number of subjects: 141

Group type: COMPARATOR
Intervention: Conventional instructor led training
Number of subjects: 141
Study: 29461870

Group type: EXPERIMENTAL
Intervention: Treatment A (PR2.3.1)
Number of subjects: 57
Study: 28361824

Group type: EXPERIMENTAL
Intervention: Foxtail millet dosa
Number of subjects: 105

Group type: COMPARATOR
Intervention: Rice dosa
Number of subjects: 105
Study: 25630582

Group type: EXPERIMENTAL
Intervention: Topical spot-on formulation containing 6.76% w/v fipronil + 50.48% w/v permethrin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 16
Study: 23087736

Group type: EXPERIMENTAL
Intervention: 0.12% CHX
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.2% CHX
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 20333793

Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 23 test foods
Number of subjects: 15
Study: 18565817

Group type: EXPERIMENTAL
Intervention: Selenium therapy (L-seleno-methionine 2 x 100 microg/day for one year)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Selenium therapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 132
Study: 15717211

Group type: EXPERIMENTAL
Intervention: 20 mg of sarizotan
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12760988

Group type: EXPERIMENTAL
Intervention: Dexamethasone (n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Saline (n = 32)
Number of subjects: 64
Study: 10713870

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 134

Group type: COMPARATOR
Intervention: droperidol 75 micrograms kg‐1
Number of subjects: 134
Study: 8722064

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441